Beyond the blood: expanding CAR T cell therapy to solid tumors
Nature Biotechnology · 2025-04 · 43 (4) · 506-515
DOI: 10.1038/s41587-024-02446-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nature Biotechnology, online erschienen am 12.11.2024. Verfasst von Ugur Uslu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Neoplasms, Receptors, Chimeric Antigen, T-Lymphocytes. Die Arbeit wurde bisher 172-mal zitiert (Crossref) und nennt 113 Literaturangaben.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR) T cell therapy stands as a transformative advancement in immunotherapy, triumphing against hematological malignancies and, increasingly, autoimmune disorders. After a decade of relatively modest results for solid tumors, recent clinical trials and patient reports have also started to yield promising outcomes in glioblastoma and other challenging solid tumor entities. This Perspective seeks to explore the reasons behind these latest achievements and discusses how they can be sustained and expanded through different strategies involving CAR engineering and synthetic biology. Furthermore, we critically analyze how these breakthroughs can be leveraged to maintain momentum and broaden the therapeutic impact of CAR T cells across a variety of solid tumor landscapes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
- Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
- Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
- Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
Zitieren
APA
Uslu, U., & June, C. H. (2025). Beyond the blood: expanding CAR T cell therapy to solid tumors. Nature Biotechnology, 43(4), 506-515. https://doi.org/10.1038/s41587-024-02446-2
Vancouver
Uslu U, June CH. Beyond the blood: expanding CAR T cell therapy to solid tumors. Nature Biotechnology. 2025;43(4):506-515. doi:10.1038/s41587-024-02446-2
BibTeX
@article{Uslu2025,
author = {Uslu, Ugur and June, Carl H},
title = {Beyond the blood: expanding CAR T cell therapy to solid tumors},
journal = {Nature Biotechnology},
year = {2025},
volume = {43},
number = {4},
pages = {506--515},
doi = {10.1038/s41587-024-02446-2}
}
EUVIMED